Skip to main content
    M

    MIRA Pharmaceuticals, Inc. Common Stock (MIRA)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ

    $0.63
    -0.03 (-4.37%)

    Market Cap: $27.73M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    MIRA Pharmaceuticals, Inc. Common Stock (MIRA) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect MIRA Pharmaceuticals, Inc. Common Stock (MIRA) to earn -$0.12 per share in the fiscal year ending Dec 31, 2026. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.16.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a larger loss.

    Fiscal year ending Dec 31, 2026
    -$0.12
    EPS consensus
    Fiscal year ending Dec 31, 2027
    -$0.16
    EPS consensus
    Next report
    Mar 29, 2027
    Estimated

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$0.12-$0.12 to -$0.121
    Dec 31, 2027-$0.16-$0.16 to -$0.161

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 1 upward and 0 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202610
    Fiscal year ending Dec 31, 202700

    Frequently Asked Questions About MIRA

    What is the MIRA stock forecast?

    Consensus analyst estimates put MIRA Pharmaceuticals, Inc. Common Stock's EPS at -$0.12 for the fiscal year ending Dec 31, 2026.

    What EPS do analysts expect from MIRA next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.12, with estimates from -$0.12 to -$0.12 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.16, with estimates from -$0.16 to -$0.16 from 1 analyst.

    How many analysts cover MIRA?

    1 analyst estimates EPS for MIRA Pharmaceuticals, Inc. Common Stock for the fiscal year ending Dec 31, 2026.